Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: A comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Povoski, Stephen P ^a   Hall, Nathan C ^b   Murrey Jr, Douglas A ^b   Chow, Andrew Z ^b   Gaglani, Jay R ^b   Bahnson, Eamonn E ^b   Mojzisik, Cathy M ^b,c   Kuhrt, Maureen P ^a   Hitchcock, Charles L ^b   Knopp, Michael V ^b   Martin Jr, Edward W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c Veeda Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CLINICAL ASSESSMENT TOOL; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE SEVERITY; ECCRINE POROCARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTRAOPERATIVE GAMMA PROBE ASSESSMENT; INTRAOPERATIVE PERIOD; LUNG CARCINOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; OVARY CARCINOMA; PLASMACYTOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RADIOACTIVITY; RETROSPECTIVE STUDY; SARCOMA; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; CLINICAL TRIAL; FEASIBILITY STUDY; LYMPH NODE METASTASIS; MIDDLE AGED; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIOGRAPHY; SCINTISCANNING; TUMOR RECURRENCE; WHOLE BODY IMAGING;

ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; WHOLE BODY IMAGING;

EID: 81555237197     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-152     Document Type: Article

References (51)

1. Otsuka H, Graham M, Kubo A, Nishitani H. Clinical utility of FDG PET. J Med Invest 2004, 51:14-19. 10.2152/jmi.51.14, 15000251.
2. Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, Ishikita T, Koyama K. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol 2006, 11:286-296. 10.1007/s10147-006-0595-0, 16937302.
3. Maldonado A, González-Alenda FJ, Alonso M, Sierra JM. PET-CT in clinical oncology. Clin Transl Oncol 2007, 9:494-505. 10.1007/s12094-007-0093-5, 17720652.
4. Otsuka H, Morita N, Yamashita K, Nishitani H. FDG-PET/CT for cancer management. J Med Invest 2007, 54:195-199. 10.2152/jmi.54.195, 17878667.
5. Vallabhajosula S. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med 2007, 37:400-419. 10.1053/j.semnuclmed.2007.08.004, 17920348.
6. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 2009, 70:382-392. 10.1016/j.ejrad.2009.03.051, 19406595.
7. Vriens D, de Geus-Oei LF, van der Graaf WT, Oyen WJ. Tailoring therapy in colorectal cancer by PET-CT. Q J Nucl Med Mol Imaging 2009, 53:224-244.
8. Desai D, Arnold M, Saha S, Hinkle G, Soble D, Frye J, DePalatis L, Mantil J, Satter M, Martin E. Intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging 1999, 2:325. 10.1016/S1095-0397(99)00085-0, 14516622.
9. Desai DC, Arnold M, Saha S, Hinkle G, Soble D, Fry J, DePalatis LR, Mantil J, Satter M, Martin EW. Correlative whole-body FDG-PET and intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging 2000, 3:189-196. 10.1016/S1095-0397(00)00052-2, 11348847.
10. Zervos EE, Desai DC, DePalatis LR, Soble D, Martin EW. 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. J Surg Res 2001, 97:9-13. 10.1006/jsre.2001.6092, 11319873.
11. Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F. Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001, 96:120-126. 10.1006/jsre.2000.6069, 11181005.
12. Essner R, Daghighian F, Giuliano AE. Advances in FDG PET probes in surgical oncology. Cancer J 2002, 8:100-108. 10.1097/00130404-200203000-00004, 11999944.
13. Higashi T, Saga T, Ishimori T, Mamede M, Ishizu K, Fujita T, Mukai T, Sato S, Kato H, Yamaoka Y, Matsumoto K, Senda M, Konishi J. What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study. Ann Nucl Med 2004, 18:105-114. 10.1007/BF02985100, 15195757.
14. Carrera D, Fernandez A, Estrada J, Martin-Comin J, Gamez C. [Detection of occult malignant melanoma by 18F-FDG PET-CT and gamma probe]. Rev Esp Med Nucl 2005, 24:410-413. [Spanish], 10.1016/S0212-6982(05)74186-0, 16324518.
15. Franc BL, Mari C, Johnson D, Leong SP. The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med 2005, 30:787-791. 10.1097/01.rlu.0000186856.86505.96, 16319633.
16. Kraeber-Bodéré F, Cariou B, Curtet C, Bridji B, Rousseau C, Dravet F, Charbonnel B, Carnaille B, Le Néel JC, Mirallié E. Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases. Surgery 2005, 138:1176-1182. 10.1016/j.surg.2005.08.028, 16360406.
17. Barranger E, Kerrou K, Petegnief Y, David-Montefiore E, Cortez A, Daraï E. Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecol Oncol 2005, 96:241-244. 10.1016/j.ygyno.2004.09.030, 15589609.
18. Meller B, Sommer K, Gerl J, von Hof K, Surowiec A, Richter E, Wollenberg B, Baehre M. High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer. Nuklearmedizin 2006, 45:153-159.
19. Gulec SA, Daghighian F, Essner R. PET-Probe. Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery. Ann Surg Oncol 2006,
20. Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T. Radioguided detection of lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg 2006, 82:1815-1820. discussion 1820, 10.1016/j.athoracsur.2006.05.104, 17062254.
21. Gulec SA, Hoenie E, Hostetter R, Schwartzentruber D. PET probe-guided surgery: applications and clinical protocol. World J Surg Oncol 2007, 5:65. 10.1186/1477-7819-5-65, 1896163, 17555587.
22. Sarikaya I, Povoski SP, Al-Saif OH, Kocak E, Bloomston M, Marsh S, Cao Z, Murrey DA, Zhang J, Hall NC, Knopp MV, Martin EW. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. World J Surg Oncol 2007, 5:80. 10.1186/1477-7819-5-80, 1941735, 17634125.
23. Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW. Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer. World J Surg Oncol 2007, 5:143. 10.1186/1477-7819-5-143, 2235860, 18154677.
24. Sun D, Bloomston M, Hinkle G, Al-Saif OH, Hall NC, Povoski SP, Arnold MW, Martin EW. Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future. J Surg Oncol 2007, 96:297-308. 10.1002/jso.20869, 17726663.
25. Gulec SA. PET probe-guided surgery. J Surg Oncol 2007, 96:353-357. 10.1002/jso.20862, 17726667.
26. Piert M, Burian M, Meisetschlager G, Stein HJ, Ziegler S, Nahrig J, Picchio M, Buck A, Siewert JR, Schwaiger M. Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging 2007, 34:1534-1544. 10.1007/s00259-007-0430-5, 2562440, 17431612.
27. Curtet C, Carlier T, Mirallié E, Bodet-Milin C, Rousseau C, Barbet J, Kraeber-Bodéré F. Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence. Eur J Nucl Med Mol Imaging 2007, 34:1556-1562. 10.1007/s00259-007-0393-6, 17522858.
28. Povoski SP, Hall NC, Martin EW, Walker MJ. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma. World J Surg Oncol 2008, 6:1. 10.1186/1477-7819-6-1, 2246138, 18186915.
29. Cohn DE, Hall NC, Povoski SP, Seamon LG, Farrar WB, Martin EW. Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer. Gynecol Oncol 2008, 110:152-157. 10.1016/j.ygyno.2008.04.026, 18539314.
30. Moffatt-Bruce SD, Povoski SP, Sharif S, Hall NC, Ross P, Johnson MA, Martin EW. A novel approach to positron emission tomography in lung cancer. Ann Thorac Surg 2008, 86:1355-1357. 10.1016/j.athoracsur.2008.03.072, 18805196.
31. Agrawal A, Hall NC, Ringel MD, Povoski SP, Martin EW. Combined use of perioperative TSH-stimulated 18F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma. Laryngoscope 2008, 118:2190-2194. 10.1097/MLG.0b013e3181845738, 18978509.
32. Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW. Bringing advanced medical imaging into the operative arena could revolutionize the surgical care of cancer patients. Expert Rev Med Devices 2008, 5:663-667. 10.1586/17434440.5.6.663, 19025340.
33. Povoski SP, Sarikaya I, White WC, Marsh SG, Hall NC, Hinkle GH, Martin EW, Knopp MV. Comprehensive evaluation of occupational radiation exposure to intraoperative and perioperative personnel from 18F-FDG radioguided surgical procedures. Eur J Nucl Med Mol Imaging 2008, 35:2026-2034. 10.1007/s00259-008-0880-4, 18618106.
34. Piert M, Carey J, Clinthorne N. Probe-guided localization of cancer deposits using [(18)F]fluorodeoxyglucose. Q J Nucl Med Mol Imaging 2008, 52:37-49.
35. van Baardwijk A, Bosmans G, van Suylen RJ, van Kroonenburgh M, Hochstenbag M, Geskes G, Lambin P, De Ruysscher D. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. Radiother Oncol 2008, 87:55-58. 10.1016/j.radonc.2008.02.002, 18328584.
36. Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA, Knopp MV, Martin EW. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol 2009, 7:11. 10.1186/1477-7819-7-11, 2653072, 19173715.
37. Murrey DA, Bahnson EE, Hall NC, Povoski SP, Mojzisik CM, Young DC, Sharif S, Johnson MA, Abdel-Misih S, Martin EW, Knopp MV. Perioperative (18)F-fluorodeoxyglucose-guided imaging using the becquerel as a quantitative measure for optimizing surgical resection in patients with advanced malignancy. Am J Surg 2009, 198:834-840. 10.1016/j.amjsurg.2009.08.014, 19969138.
38. Molina MA, Goodwin WJ, Moffat FL, Serafini AN, Sfakianakis GN, Avisar E. Intra-operative use of PET probe for localization of FDG avid lesions. Cancer Imaging 2009, 9:59-62. 10.1102/1470-7330.2009.9025, 2792082, 19933018.
39. Gollub MJ, Akhurst TJ, Williamson MJ, Shia J, Humm JL, Wong WD, Paty PB, Guillem JG, Weiser MR, Temple LK, Dauer LT, Jhanwar SC, Kronman RE, Montalvo CV, Miller AR, Larson SM, Margulis AR. Feasibility of ex vivo FDG PET of the colon. Radiology 2009, 252:232-239. 10.1148/radiol.2522081864, 19561258.
40. Hall NC, Povoski SP, Murrey DA, Martin EW, Knopp MV. Ex vivo specimen FDG PET/CT imaging for oncology. Radiology 2010, 255:663-64. 10.1148/radiol.092400, 20413781.
41. Nalley C, Wiebeck K, Bartel TB, Bodenner D, Stack BC. Intraoperative radiation exposure with the use of (18)F-FDG-guided thyroid cancer surgery. Otolaryngol Head Neck Surg 2010, 142:281-283. 10.1016/j.otohns.2009.11.005, 20115989.
42. de Jong JS, van Ginkel RJ, Slart RH, Lemstra CL, Paans AM, Mulder NH, Hoekstra HJ. FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrences. Eur J Surg Oncol 2010, 36:1092-1095. 10.1016/j.ejso.2010.08.129, 20828977.
43. Hartemink KJ, Muller S, Smulders YM, Petrousjka van den Tol M, Comans EF. [Fluorodeoxyglucose F18(FDG)-probe guided biopsy]. Ned Tijdschr Geneeskd 2010, 154:A1884. [Dutch].
44. Lee GO, Costouro NG, Groome T, Kashani-Sabet M, Leong SPL. The use of intraoperative PET probe to resect metastatic melanoma. BMJ Case Reports 2010,
45. García JR, Fraile M, Soler M, Bechini J, Ayuso JR, Lomeña F. [PET/CT-guided salvage surgery protocol. Results with ROLL Technique and PET probe]. Rev Esp Med Nucl 2011, 30:217-222. [Spanish], 10.1016/j.remn.2011.02.011, 21514975.
46. Kim WW, Kim JS, Hur SM, Kim SH, Lee SK, Choi JH, Kim S, Choi JY, Lee JE, Kim JH, Nam SJ, Yang JH, Choe JH. Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: A pilot study. Surgery 2011, 149:416-424. 10.1016/j.surg.2010.08.004, 20965536.
47. Francis CL, Nalley C, Fan C, Bodenner D, Stack BC. 18F-fluorodeoxyglucose and 131I Radioguided Surgical Management of Thyroid Cancer. Otolaryngol Head Neck Surg 2011,
48. Manca G, Biggi E, Lorenzoni A, Boni G, Roncella M, Ghilli M, Volterrani D, Mariani G. Simultaneous detection of breast tumor resection margins and radioguided sentinel node biopsy using an intraoperative electronically collimated probe with variable energy window: a case report. Clin Nucl Med 2011, 36:e196-e198. 10.1097/RLU.0b013e31821c9a4c, 22064108.
49. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MG, Zubal G, Kachelriess M, Cronin V, Holbrook S. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 2006, 47:885-895.
50. American College of Radiology (ACR) Practice Guidelines for Performing FDG-PET/CT in Oncology. 2009, 1-10., http://www.acr.org/secondarymainmenucategories/quality_safety/guidelines/nuc_med/fdg_pet_ct.aspx
51. United States Nuclear Regulatory Commission (1991). Section 20.1201 - Occupational Dose Limits for Adults, Subpart C - Occupational Dose Limits, Part 20 - Standards for Protection Against Radiation, Chapter I - Nuclear Regulatory Commission, NRC Regulations Title 10 of the Code of Federal Regulations. , http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/full-text.html